浅析注射用哌拉西林钠舒巴坦钠治疗急性细菌性感染的临床效果

The Clinical Effect of Piperacillin Sodium and Sulbactam Sodium Injection for the Treatment of Acute Bacterial Infections

目的 研究分析急性细菌性感染使用哌拉西林钠舒巴坦钠注射治疗的效果和临床安全性。方法 选取我院2012年10月-2013年10月收治的48例急性细菌性感染患者作为研究对象,将其随机分为对照组和观察组。对照组使用哌拉西林钠他唑巴坦钠治疗,观察组使用哌拉西林钠舒巴坦钠治疗,对两组的治疗情况进行对比分析。结果 观察组的临床治疗有效率为95.83%,对照组的治疗有效率为91.67%;观察组不良反应率为4.17%,对照组不良反应率为8.33%,两组数据对比,差异不具有统计学意义（P〉0.05）。观察组的治疗成本低于对照组（P〈0.05）。结论 急性细菌性感染可以选择哌拉西林钠舒巴坦钠与哌拉西林钠他唑巴坦钠治疗,临床安全有效,哌拉西林钠舒巴坦钠的治疗成本较低。

Objective To study the acute bacterial infection using piperacillin sodium and sulbactam sodium for injection in the treatment of the clinical effect and safety.MethodsFrom October 2012 to October 2013 in our hospital, 48 cases of acute bacterial infection patients were analyzed and were divided into the observation group and the control group, the control group was using by piperacillin sodium and tazobactam sodium, the observation group was using by piperacillin sodium and sulbactam sodium, compared to the treatment group two cases.ResultsThe clinical effective rate in the treatment group was 95.83%, the control group the effective rate was 91.67%. The adverse reaction rate of the observation group was 4.17%, the control group was 8.33%, there were no significant differences （P 〉0.05）. The treatment cost of the observation group was lower than that ofthe control group （P 〈 0.05）.Conclusion The option of piperacillin sodium and sulbactam sodium and piperacillin sodium and tazobactam sodium in the treatment of acute bacterial infection, clinical safety and effectiveness, the treatment cost of piperacillin sodium and sulbactam sodium is low.